In GBM, increased CcO activity and increased expression of CcO subunit 4 isoform 1 (COX4-1) have been associated with acquisition of TMZ chemoresistance [12] as well as shorter progression-free and overall survival of patients [23]. Here, COX4I1 is linked to glioblastoma.